Beacon Pointe Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$362K	Buy	+7,446	New	+$362K	﹤0.01%	976
2024 Q2	–	Sell	-6,334	Closed	-$432K	–	1264
2024 Q1	$432K	Buy	6,334 +2,566	+68%	+$175K	﹤0.01%	961
2023 Q4	$236K	Buy	+3,768	New	+$236K	﹤0.01%	1140